Abstract:Abstract There has been an increasing role in the use of injectable fillers for rejuvenation of the aging face. In this systematic review, we aim to evaluate the existing literature related to soft tissue fillers of the midface. Specifically, we focus on the non-hyaluronic acid fillers including polymethylmethacrylate (PMMA), poly-L-lactic acid (PLLA), calcium hydroxyapatite (CaHA), and autologous fat. A systematic review was conducted in November 2020 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines with PubMed and Embase databases. Medical Subject Headings terms used were “cheek” OR “midface” OR “malar” and “filler” OR “poly-L-lactic acid” OR “calcium hydroxyapatite,” “autologous fat” OR “polymethylmethacrylate” OR “Artefill” OR “Bellafill” OR “Radiesse” OR “Sculptra.” The initial search identified 271 articles. After 145 duplicates were removed, 126 studies were screened for relevance by title and abstract. A total of 114 studies were eliminated based on inclusion and exclusion criteria. Twelve articles underwent full-text review. Seven articles were included in the final analysis consisting of four non-hyaluronic filler products: PMMA, PLLA, CaHA, autologous fat. Most patients were highly satisfied with their results. Due to the gradual volumizing effects of PMMA, PLLA, and CaHA, patient satisfaction generally improved over time. Minor adverse reactions related to treatment included bruising, swelling, and pain. Nodule formation was reported in PLLA and CaHA studies. For autologous fat, 32% of the original injection volume remained at 16 months post-treatment, which still provided clinically improved malar enhancement. Dermal fillers are an attractive treatment option for the aging face due to their high patient satisfaction, long-lasting effects, and low side-effect profile. Patients should be appropriately counseled on the delayed effects of non-HA fillers. Autologous fat is a good option in many patients with the major drawback of unpredictable longevity, which may require a secondary procedure. Future studies should examine the longevity and long-term side effects of these fillers.

Hyaluronic Acid Fillers: Where We Have Been and Where We Are Going

Semipermanent and permanent injectable fillers

Injectable fillers: review of material and properties

Injectable soft-tissue fillers: clinical overview

A Novel Hybrid Injectable for Soft-tissue Augmentation: Analysis of Data and Practical Experience

Intracorporeal evaluation of hyaluronic acid fillers with varied rheological properties and correlations with aesthetic outcomes

Crosslinking hyaluronic acid soft-tissue fillers: current status and perspectives from an industrial point of view

An overview of permanent and semipermanent fillers

Rheological Characteristics of Hyaluronic Acid Fillers as Viscoelastic Substances

The rheology of injectable hyaluronic acid hydrogels used as facial fillers: A review

Decomposition and Changes in In Vivo Post‐HA Filler Injection: A Review

The Hybrid Filler Technique: A 5-Year Retrospective Analysis

Evaluation of the Filling Effects and Safety of an Injectable Gel Based on A Multi-Crosslinked Hyaluronan (Mu.C.H) Technology for the Correction of Facial Ageing Defects

Facial rejuvenation with the new hybrid filler HArmonyCa™: Clinical and aesthetic outcomes assessed by 2D and 3D photographs, ultrasound, and elastography

In Vitro Cytocompatibility Analysis and Comparison of Different Hyaluronic Acid Fillers for Minimally Invasive Esthetics

Blending Hyaluronic Acid and Calcium Hydroxylapatite for Injectable Facial Dermal Fillers: A Clinical and Ultrasonography Assessment

Hyaluronic Acid After Subcutaneous Injection—An Objective Assessment

Expanding Treatment Options for Injectable Agents

Non-Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review

Comparative analysis of in vivo bio-integration of three hyaluronic acid-based fillers for 26 weeks: a histological study

Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)—Implications for Therapeutic Interventions